Skip to main content

Peer Review reports

From: How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review

Original Submission
1 Jan 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
17 Jan 2021 Reviewed Reviewer Report
27 Jan 2021 Reviewed Reviewer Report - Olivia Wu
10 Apr 2021 Author responded Author comments - Mikyung Kelly Seo
Resubmission - Version 3
10 Apr 2021 Submitted Manuscript version 3
12 Apr 2021 Author responded Author comments - Mikyung Kelly Seo
Resubmission - Version 4
12 Apr 2021 Submitted Manuscript version 4
16 Apr 2021 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
16 Aug 2021 Editorially accepted
1 Sep 2021 Article published 10.1186/s12885-021-08725-4

You can find further information about peer review here.

Back to article page